Biochemistry 60 (48), 36763696
10.1056/NEJM200007203430304 N Engl J Med
Cell 187 , 74147432.e7426 (2024)
Theoretically, selective ET A R antagonists should be more effective than dual ERAs in that they only target the vasoconstrictive and mitogenic activities of ET-1ET A R, while preserving the vasodilatory and antimitogenic effect of ET-1ET B R.59 Despite its selectivity for ET A R, ambrisentan has not shown greater efficacy in non-comparative monotherapy clinical trials, compared with bosentan.60 This may be because the distribution or function of ET B R is altered in disease states, and thus dual receptor blockers appear to perform as well as those ERAs with a specific target.61 Unlike bosentan, ambrisentan was not associated with elevated liver toxicity,62 ,32 but peripheral oedema was reported more frequently compared with placebo.27 Details of the ARIES-1 and ARIES-2 trials are given in table 3, and the ARIES-E extension study is detailed in table 4

Technical Information INCI Name: Copper Tripeptide-1 Common Name: GHK-Cu (Copper Peptide) Appearance: Bright blue to deep-blue fine powder Chemical Composition GHK-Cu is a copper-binding tripeptide complex composed of: Glycine L-Histidine L-Lysine Copper ions (Cu) Molecular Formula: CHNOCu Solubility: Water soluble Recommended Cosmetic Applications Suitable for cosmetic formulations including: Serums Creams Gel formulations Scalp formulations Cosmetic skincare applications Grade: Cosmetic-Grade Raw Powder Storage Guidelines Store in a cool, dry environment Protect from direct sunlight and excessive heat Keep container tightly sealed between uses Avoid moisture exposure during handling For Cosmetic Formulation and Research Use Only Not for injection or human consumption